150 related articles for article (PubMed ID: 37683801)
1. Clinical Features, Epidemiology, Management and Prognosis of Patients With Primary Cutaneous Marginal Zone Lymphoma: An Observational Study.
Gómez Arias PJ; Vázquez Díaz S; Rothenberg Lausell C; Sanz Zorrilla A; Baleato Gómez B
Actas Dermosifiliogr; 2024 Jan; 115(1):106-109. PubMed ID: 37683801
[No Abstract] [Full Text] [Related]
2. Clinical Features, Epidemiology, Management and Prognosis of Patients With Primary Cutaneous Marginal Zone Lymphoma: An Observational Study.
Gómez Arias PJ; Vázquez Díaz S; Rothenberg Lausell C; Sanz Zorrilla A; Baleato Gómez B
Actas Dermosifiliogr; 2024 Jan; 115(1):T106-T109. PubMed ID: 37838228
[No Abstract] [Full Text] [Related]
3. Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2013 Jan; 88(1):73-6. PubMed ID: 23379008
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous B-cell lymphoma: subtypes, treatment and outcome of 10 cases.
Onsun N; Su O; Kural YB; Erdemoglu Y; Buyukbabani N; Demirkesen C; Aydin Y
Acta Derm Venereol; 2011 Jun; 91(4):476-8. PubMed ID: 21537819
[No Abstract] [Full Text] [Related]
5. Primary cutaneous marginal zone B-cell lymphoma: clinical and histological aspects.
Khaled A; Sassi S; Fazaa B; Ben Hassouna J; Ben Romdhane K; Kamoun MR
Pathologica; 2009 Feb; 101(1):18-20. PubMed ID: 19771768
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management.
Wilcox RA
Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522
[TBL] [Abstract][Full Text] [Related]
7. Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
Juárez-Salcedo LM; Castillo JJ
Hematol Oncol Clin North Am; 2019 Aug; 33(4):639-656. PubMed ID: 31229160
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
[TBL] [Abstract][Full Text] [Related]
9. Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature.
Magro CM; Yang A; Fraga G
Am J Dermatopathol; 2013 May; 35(3):319-26. PubMed ID: 23190506
[TBL] [Abstract][Full Text] [Related]
10. How I Diagnose Primary Cutaneous Marginal Zone Lymphoma.
Gibson SE; Swerdlow SH
Am J Clin Pathol; 2020 Sep; 154(4):428-449. PubMed ID: 32808967
[TBL] [Abstract][Full Text] [Related]
11. Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review.
van den Brand M; van Krieken JH
Haematologica; 2013 Jul; 98(7):1003-13. PubMed ID: 23813646
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Management of Cutaneous B-cell Lymphoma.
Pinter-Brown LC
Dermatol Clin; 2015 Oct; 33(4):835-40. PubMed ID: 26433853
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous marginal zone lymphomas.
Swerdlow SH
Semin Diagn Pathol; 2017 Jan; 34(1):76-84. PubMed ID: 27986434
[TBL] [Abstract][Full Text] [Related]
14. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Zucca E; Arcaini L; Buske C; Johnson PW; Ponzoni M; Raderer M; Ricardi U; Salar A; Stamatopoulos K; Thieblemont C; Wotherspoon A; Ladetto M;
Ann Oncol; 2020 Jan; 31(1):17-29. PubMed ID: 31912792
[No Abstract] [Full Text] [Related]
15. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.
Suárez AL; Pulitzer M; Horwitz S; Moskowitz A; Querfeld C; Myskowski PL
J Am Acad Dermatol; 2013 Sep; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984
[TBL] [Abstract][Full Text] [Related]
16. Controversies and considerations in the diagnosis of primary cutaneous CD4⁺ small/medium T-cell lymphoma.
Lan TT; Brown NA; Hristov AC
Arch Pathol Lab Med; 2014 Oct; 138(10):1307-18. PubMed ID: 25268194
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous marginal-zone lymphoma.
Farhadian J; Terushkin V; Meehan SA; Latkowski JA
Dermatol Online J; 2016 Dec; 22(12):. PubMed ID: 28329553
[TBL] [Abstract][Full Text] [Related]
18. Management of the marginal zone lymphomas.
Vannata B; Stathis A; Zucca E
Cancer Treat Res; 2015; 165():227-49. PubMed ID: 25655612
[TBL] [Abstract][Full Text] [Related]
19. Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Zucca E; Dreyling M;
Ann Oncol; 2008 May; 19 Suppl 2():ii70-1. PubMed ID: 18456776
[No Abstract] [Full Text] [Related]
20. [Management of cutaneous B-cell lymphoma: recommendations of the French cutaneous lymphoma study group].
Grange F; D'Incan M; Ortonne N; Dalac S; Laroche L; Beylot-Barry M; Delfau-Larue MH; Vergier B; Bagot M;
Ann Dermatol Venereol; 2010; 137(8-9):523-31. PubMed ID: 20804896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
